Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop
growing or die. Imatinib mesylate may stop the growth of cancer cells by blocking the enzymes
necessary for cancer cell growth. Combining more than one chemotherapy drug with imatinib
mesylate may kill more cancer cells. Randomized phase II trial to study the effectiveness of
combination chemotherapy and imatinib mesylate in treating children who have relapsed acute
lymphoblastic leukemia.